Biomarin Pharmaceutical (LTS:0HNC) Other Long Term Assets : $1,696 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Biomarin Pharmaceutical Other Long Term Assets?

Biomarin Pharmaceutical's other long-term assets for the quarter that ended in Mar. 2025 was $1,696 Mil.

Biomarin Pharmaceutical's quarterly other long-term assets increased from Sep. 2024 ($1,730 Mil) to Dec. 2024 ($1,741 Mil) but then stayed the same from Dec. 2024 ($1,741 Mil) to Mar. 2025 ($1,696 Mil).

Biomarin Pharmaceutical's annual other long-term assets increased from Dec. 2022 ($1,682 Mil) to Dec. 2023 ($1,717 Mil) and increased from Dec. 2023 ($1,717 Mil) to Dec. 2024 ($1,741 Mil).

Biomarin Pharmaceutical Other Long Term Assets Historical Data

The historical data trend for Biomarin Pharmaceutical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical Other Long Term Assets Chart

Biomarin Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

1,574.39

1,602.28

1,681.65

1,717.35

1,740.76

Biomarin Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															1,730.83	1,735.78	1,730.09	1,740.76	1,696.22

Biomarin Pharmaceutical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Biomarin Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (LTS:0HNC) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

BMRN:USA BMRN:Mexico 1BMRN:Italy BM8:Germany BM8:Germany B1MR34:Brazil BMRN:Austria

Address

770 Lindaro Street, San Rafael, CA, USA, 94901

Website

https://www.biomarin.com

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

Biomarin Pharmaceutical Headlines

No Headlines